Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p78
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 78/162)
Character Range: 15072189–15081137

or mid portion of a vertebral body relative to the posterior height of that body, or, a 20% or greater reduction in any of these heights compared to the vertebral body above or below the affected vertebral body.
C14296              P14296         CN14296          Calcitriol                                           Vitamin D-resistant rickets                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 14296
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
C14298              P14298         CN14298          Rivaroxaban                                          Chronic stable atherosclerotic disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures - Streamlined Authority Code 14298
                                                                                                         Continuing treatment
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must have received PBS-subsidised treatment with this drug for this condition; AND
                                                                                                         The treatment must be in combination with aspirin, but not with any other anti-platelet therapy.
C14300              P14300         CN14300          Apixaban                                             Prevention of recurrent venous thromboembolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures - Streamlined Authority Code 14300
                                                                                                         Continuing treatment
                                                    Rivaroxaban                                          The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must have a history of venous thromboembolism.
C14301              P14301         CN14301          Apixaban                                             Prevention of stroke or systemic embolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Compliance with Authority Required procedures - Streamlined Authority Code 14301
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Dabigatran etexilate                                 Patient must have non-valvular atrial fibrillation; AND
                                                                                                         Patient must have one or more risk factors for developing stroke or systemic embolism.
                                                    Rivaroxaban                                          Risk factors for developing stroke or systemic ischaemic embolism are
                                                                                                         (i) Prior stroke (ischaemic or unknown type), transient ischaemic attack or non-central nervous system (CNS) systemic embolism;
                                                                                                         (ii) age 75 years or older;
                                                                                                         (iii) hypertension;
                                                                                                         (iv) diabetes mellitus;
                                                                                                         (v) heart failure and/or left ventricular ejection fraction 35% or less.
C14305              P14305         CN14305          Atenolol                                             For a patient who is unable to take a solid dose form of atenolol.
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
C14306              P14306         CN14306          Balsalazide                                          Ulcerative colitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 14306
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must have had a documented hypersensitivity reaction to a sulphonamide.  or
                                                                                                         Patient must be intolerant to sulfasalazine.
C14309              P14309         CN14309          Alendronic acid                                      Corticosteroid-induced osteoporosis
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must currently be on long-term (at least 3 months), high-dose (at least